24 Nov 2016 | Our stories
What might the economic costs of antibiotic/antimicrobial-resistant infections be in New Zealand? The simple answer is – we don’t know. As far as I’m aware, there’s been no New Zealand studies publicly disseminated on this topic. Therefore, we have to look overseas...
24 Nov 2016 | Our stories
Down in Otago, researchers’ focus on microbiology fundamentals is leading New Zealand’s fight against drug resistant pathogens. In May 2016 the UK government’s Review on Antimicrobial Resistance (AMR) published its final report, summarising the Review’s findings from...
24 Nov 2016 | Our stories
We are nearing a crisis point in our use (and, sadly, misuse) of antibiotics. Indeed, the World Health Organisation recently described humanity as being in “a race against time” to develop antibiotics against multi-drug resistant superbugs [i]. If we cannot find...
24 Nov 2016 | Our stories
Heart defects are collectively the commonest abnormality in newborn babies. About one infant in every 150 has some form of defect; a hole in the heart, or parts of the heart underdeveloped or in the wrong place. Four hundred children every year undergo heart surgery...
23 Nov 2016 | Our stories
Last week was World Antibiotic Awareness week, an initiative of the World Health Organization (WHO) to raise awareness and understanding of antimicrobial resistance. To follow-up, here at Te Pūnaha Matatini we are having a week-long conversation about the health,...
